ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Solicits Grant applications For New Type Of Small Business Award; 40 To Be Funded

September 10, 1993

Clinical Trials Approved By NCI CTEP Last Month

March 25, 2011

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

Task Force Urges HHS to Form Committee To Implement Genetic Testing Regulations

November 7, 1997

In Brief: FDA Seeks Applicants For Oncology Div. Head; Croce Wins Pasarow Award; CRI Honors Five

August 18, 1995

Standard Surgical Protocol Improved Endometrial Staging

October 27, 2006